NCT02818335View on ClinicalTrials.gov

A Study of LY3023414 Formulations and the Effect of Food

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Healthy
Interventions
DRUG

LY3023414 Reference Fasted

Administered Orally

DRUG

LY3023414 Test Fasted

Administered Orally

DRUG

LY3023414 Test Fed

Administered Orally

Trial Locations (1)

32117

Covance Clinical Research Inc, Daytona Beach

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02818335 - A Study of LY3023414 Formulations and the Effect of Food | Biotech Hunter | Biotech Hunter